-transparent.png){kind=logo}
The concentration-effect relationship of 0.25 mg intravenous timolol with and without pretreatment with 100 mg quinidine was studied in six healthy young volunteers with a randomized, double-blind, crossover study design. Blockade of cardiac beta-adrenoceptors was assessed by determining the dose ratios (DR) of isoproterenol infusions required to increase heart rate by 25 beats/min before and after timolol infusion. The logarithm of timolol concentration in plasma was linearly related to the logarithm (DR-1) of isoproterenol infusion, with a mean Pearson correlation coefficient of 0.89 +/- 0.11 (+/- SD; n = 24) at timolol concentrations well below 1 ng/ml. The increases in cyclic adenosine monophosphate (cAMP) and norepinephrine plasma levels caused by isoproterenol infusions were attenuated after timolol. Quinidine administration increased timolol plasma levels and cardiac beta-blocking effects by 10% to 40%. It was concluded that timolol at concentrations below 1 ng/ml in plasma competitively antagonizes cardiac and noncardiac effects of isoproterenol infusions. Timolol effects are augmented after quinidine administration. The beta-blockade occurring at low plasma levels can explain side effects and actions of ocularly applied timolol.
T Kaila, and
R Huupponen, and
S Karhuvaara, and
P Havula, and
M Scheinin, and
E Iisalo, and
L Salminen
November 1982,
British journal of clinical pharmacology,
T Kaila, and
R Huupponen, and
S Karhuvaara, and
P Havula, and
M Scheinin, and
E Iisalo, and
L Salminen
January 1993,
European journal of clinical pharmacology,
T Kaila, and
R Huupponen, and
S Karhuvaara, and
P Havula, and
M Scheinin, and
E Iisalo, and
L Salminen
February 1976,
European journal of pharmacology,
T Kaila, and
R Huupponen, and
S Karhuvaara, and
P Havula, and
M Scheinin, and
E Iisalo, and
L Salminen
December 1982,
Clinical pharmacology and therapeutics,
T Kaila, and
R Huupponen, and
S Karhuvaara, and
P Havula, and
M Scheinin, and
E Iisalo, and
L Salminen
September 1973,
Archives internationales de pharmacodynamie et de therapie,
T Kaila, and
R Huupponen, and
S Karhuvaara, and
P Havula, and
M Scheinin, and
E Iisalo, and
L Salminen
April 1988,
Scandinavian journal of dental research,
T Kaila, and
R Huupponen, and
S Karhuvaara, and
P Havula, and
M Scheinin, and
E Iisalo, and
L Salminen
January 1974,
Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
T Kaila, and
R Huupponen, and
S Karhuvaara, and
P Havula, and
M Scheinin, and
E Iisalo, and
L Salminen
January 1976,
Drug metabolism and disposition: the biological fate of chemicals,
T Kaila, and
R Huupponen, and
S Karhuvaara, and
P Havula, and
M Scheinin, and
E Iisalo, and
L Salminen
January 1989,
Journal of ocular pharmacology,
T Kaila, and
R Huupponen, and
S Karhuvaara, and
P Havula, and
M Scheinin, and
E Iisalo, and
L Salminen
September 1987,
The American journal of cardiology,
